Leo Pharma is a biotech company that manufactures and markets pharmaceuticals worldwide. The company operates research production and marketing units in Denmark, factories in France, UK and Ireland, and subsidiaries in 16 other countries. Leo Pharma has specialized in dermatology, osteoporosis, renal disease and cancer. The principal products marketed are Fucidin®, Daivonex®, Burinex®, Centyl® etc. Leo Pharma invested more than 16% of the company’s turnover in R&D.